...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Changes in blood coagulation markers associated with uterine artery embolization for leiomyomata.
【24h】

Changes in blood coagulation markers associated with uterine artery embolization for leiomyomata.

机译:与子宫平滑肌瘤的子宫动脉栓塞相关的凝血标志物的变化。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To determine whether a transient hypercoagulable state is induced by the uterine artery embolization (UAE) procedure. MATERIALS AND METHODS: Serial periprocedure blood samples were obtained from 27 patients undergoing the UAE procedure. Five blood samples were obtained from each patient at set time intervals: before the procedure (for baseline determination), immediately before and after embolization of the uterine arteries, 90 minutes after conclusion of the procedure, and between 18 and 24 hours later. Each blood sample was analyzed for the peripheral levels of the following parameters: thrombin-antithrombin complex (TAT), prothrombin fragment 1.2 (F1.2), platelet factor 4 (PF4), D-dimer, and plasmin-alpha(2)-antiplasmin complex (PAP). For each parameter, the baseline values were statistically compared with the pre- and postembolization values for each individual to detect change over time. Overall and global occasion effects for continuous variables were assessed with the Friedman statisticand individual comparisons between occasions with the Wilcoxon signed-rank test. RESULTS: No evidence was found for a difference in coagulability among the five occasions for D-dimer (P =.7645) or PF4 (P =.09). All three of the remaining measures were found to have statistically significant differences (P <.0001 for F1.2, P =.0026 for PAP, and P =.0006 for TAT). No evidence was found for a difference between preprocedure and preembolization levels for these three latter parameters (P =.595 for F1.2, P =.128 for PAP, P =.9705 for TAT). Hypercoagulability potential as measured by prothrombinase and F1.2 generation increased between preembolization samples and each of the successive postprocedure samples (P <.0001, P <.0001, P =.0082), whereas PAP increased at 90 minutes (P =.0023) and TAT increased immediately after embolization (P <.0001). No clinically apparent thrombotic complications occurred among any of the patients studied. CONCLUSIONS: Surrogate markers of hypercoagulability increase as a result of UAE,suggesting that a prothrombotic state may result after the procedure.
机译:目的:确定子宫动脉栓塞术(UAE)是否诱发了短暂的高凝状态。材料与方法:收集来自27例接受阿联酋手术的患者的围手术期血样。在设定的时间间隔内从每位患者获得五份血液样本:在手术前(用于基线确定),在子宫动脉栓塞之前和之后,手术结束后90分钟以及18至24小时之后。分析每个血液样本的以下参数的外周水平:凝血酶-抗凝血酶复合物(TAT),凝血酶原片段1.2(F1.2),血小板因子4(PF4),D-二聚体和纤溶酶-alpha(2)-抗纤溶酶复合物(PAP)。对于每个参数,将基线值与每个个体的栓塞前和栓塞后值进行统计比较,以检测随时间的变化。通过弗里德曼(Friedman)统计量评估连续变量的整体和全局场合影响,并使用Wilcoxon秩和检验检验各个场合之间的个体比较。结果:没有发现证据表明五种D-二聚体(P = .7645)或PF4(P = .09)的凝血能力存在差异。其余所有三个度量均具有统计学上的显着差异(F1.2的P <.0001,PAP的P = .0026,TAT的P = .0006)。对于这三个后三个参数(F1.2的P = .595,PAP的P = .128,TAT的P = .9705),没有发现证据表明术前和栓塞前水平存在差异。通过凝血酶原酶和F1.2生成测量的高凝潜力在栓塞前样品与每个后续手术后样品之间增加(P <.0001,P <.0001,P = .0082),而PAP在90分钟时增加(P = .0023) ),栓塞后TAT立即升高(P <.0001)。在所研究的任何患者中,均未发生临床上明显的血栓并发症。结论:由于UAE,高凝性的替代标志物增加,提示手术后可能导致血栓形成状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号